(Q38796136)

6 September 2017

MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1. (English)

1 reference

6 September 2017

multiple drug resistance

1 reference

1 reference

1 reference

Di-di Wu

1

1 reference

6 September 2017

Xue-Song Li

2

1 reference

6 September 2017

Xiao-Na Meng

3

1 reference

6 September 2017

Jing Yan

4

1 reference

6 September 2017

Zhi-Hong Zong

5

1 reference

6 September 2017

5 February 2016

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

10499-10506

1 reference

6 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-016-4944-y

6 September 2017

0 references

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Adherence to treatment guidelines for ovarian cancer as a measure of quality care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MicroRNAs and their relevance to ABC transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Coordinated targeting of the EGFR signaling axis by microRNA-27a*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4944-Y

Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice

21 January 2018

1 reference

12 December 2020

Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.

1 reference

12 December 2020

Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

1 reference

12 December 2020

MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.

1 reference

12 December 2020

MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs

1 reference

12 December 2020

P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.

1 reference

12 December 2020

MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes

1 reference

12 December 2020

10.1007/S13277-016-4944-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference